If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,039.00    -17.50 (-1.66%)
Bid:
1,043.50
Ask:
1,044.50
Spread: 1.00 (0.096%)
Market Cap: £5.09b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Contract Announcement

25 Jun 2014 07:00

RNS Number : 4466K
Babcock International Group PLC
25 June 2014
 



 

25 June 2014

 

Babcock International Group PLC (Babcock, the Group)

Contract Announcement - Sellafield Silos' Maintenance Facility

 

We are delighted to announce that a joint venture led by Cavendish Nuclear, the UK's largest specialist nuclear support services organisation, with partner Balfour Beatty, has been instructed to construct a major new decommissioning support facility at Sellafield.

 

Phase 3 of the Silos' Maintenance Facility contract worth a total of £160 million, is effective immediately and follows the first two phases of work undertaken by the joint venture in preparation for the new facility. Completion of the first two phases included the £5.5 million concept and preliminary design phase, and the £12.5 million detailed design and enabling works phase. Construction is expected to be complete by 2017.

 

The joint venture, of which Cavendish Nuclear has a 55% share, will construct a new facility to service equipment to be used in the retrieval of historic radioactive waste from silos - a high-priority for hazard reduction at Sellafield. Built to exacting nuclear standards, it will provide for receipt, decontamination, inspection, maintenance and storage of retrieval equipment. The joint venture will also deliver comprehensive training for Sellafield employees in the operation of the facility.

 

The announcement further extends Cavendish Nuclear's role as a key supplier of engineering, radiological and environmental services across the Sellafield site, including the decommissioning of critical assets such as the pile fuel cladding silo and the recent successfully completed sludge treatment facility for the pile fuel storage pond. Cavendish Nuclear also continues to support the Nuclear Decommissioning Authority across its estate following the recent Preferred Bidder announcement for the Magnox/RSRL competition.

 

ENDS

 

Enquiries

Babcock International Group PLC

Terri Wright, Head of Investor Relations

Tel: 020 7355 5300

FTI Consulting

Andrew Lorenz

Nick Hasell

Tel: 020 3727 1340

07775 641 807

 

Notes to Editors

 

Cavendish Nuclear

Cavendish Nuclear is the UK's largest specialist nuclear support services organisation, with a 3,800 highly-qualified workforce. Cavendish Nuclear brings together the rich heritage of the UK's capabilities in nuclear energy to offer unrivalled experience and expertise across the life cycle of nuclear power plant. This expertise, combined with its experience as a nuclear site licensee and operator, enables Cavendish Nuclear to provide safe, effective solutions for the entire nuclear lifecycle, from design and build, through operation and maintenance, to decommissioning, waste management and remediation.

 

Cavendish Nuclear has established a world class civil nuclear engineering business with decommissioning projects in the UK and internationally as well continuing to develop its prime position within the nuclear new build programme in the UK.

 

Cavendish Nuclear is a wholly-owned subsidiary of Babcock International Group PLC. (www.cavendishnuclear.com)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFIMPTMBITBLI
Date   Source Headline
30th Jul 20213:08 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSFull year results for the year ended 31 March 2021
13th Apr 20217:00 amRNSBusiness update
7th Apr 20219:41 amRNSHolding(s) in Company
26th Feb 202110:44 amRNSHolding(s) in Company
26th Jan 20219:48 amRNSHolding(s) in Company
25th Jan 20213:19 pmRNSHolding(s) in Company
20th Jan 20212:50 pmRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSTrading update
8th Jan 20213:23 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBabcock appoints new Marine CEO
2nd Dec 20204:24 pmRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSHalf-year results
10th Nov 20207:00 amRNSDirector appointment
28th Oct 20207:00 amRNSAppointment of Chief Corporate Affairs Officer
15th Oct 20209:38 amRNSHolding(s) in Company
13th Oct 20209:00 amRNSChief Innovation & Technology Officer Appointment
9th Oct 20209:00 amRNSType 31 briefing
6th Oct 202011:21 amRNSHolding(s) in Company
30th Sep 202012:47 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSBabcock appoints new Chief Financial Officer
21st Sep 20202:56 pmRNSDirector/PDMR Shareholding
15th Sep 202010:20 amRNSDirector/PDMR Shareholding
9th Sep 20208:00 amRNSPublication of Base Prospectus
25th Aug 20209:25 amRNSHolding(s) in Company
18th Aug 20209:44 amRNSHolding(s) in Company
17th Aug 20209:11 amRNSDirector/PDMR Shareholding
14th Aug 20203:40 pmRNSDirector/PDMR Shareholding
14th Aug 20203:39 pmRNSDirector/PDMR Shareholding
4th Aug 20201:39 pmRNSDirector/PDMR Shareholding
4th Aug 202011:33 amRNSResult of AGM
4th Aug 202011:01 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSDirectorate Change
16th Jul 20209:07 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
7th Jul 202011:04 amRNSHolding(s) in Company
7th Jul 202011:02 amRNSHolding(s) in Company
1st Jul 20204:50 pmRNSNotice of AGM
1st Jul 202010:26 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSBabcock appoints new Chief Executive
11th Jun 20203:52 pmRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSFinal Results
19th May 20207:00 amRNSItalian Anti-Trust Authority decision
11th May 20207:00 amRNSRevised date for full year results and AGM
20th Apr 20207:00 amRNSDirector appointment
6th Apr 20207:00 amRNSUpdate on Coronavirus (COVID-19)
19th Mar 20202:47 pmRNSDirector/PDMR Shareholding
6th Mar 20209:43 amRNSSale of Context

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.